IFCC Committee on Standardization of Markers of Cardiac Damage: Premises and project presentation

Clinical Chemistry and Laboratory Medicine

Volumn 36, Issue 11, 1998, Pages 887-893

  Panteghini, Mauro ^a  

^a SPEDALI CIVILI   (Italy)

Author keywords

Antibodies, monoclonal; Biological markers; Myocardial infarction; Myoglobin; Troponin

Indexed keywords

BIOCHEMICAL MARKER; MYOGLOBIN; TROPONIN;

ANALYSIS; ARTICLE; ASSAY; HEART INFARCTION; HEART INJURY; HUMAN; PRIORITY JOURNAL; STANDARDIZATION;

EID: 0031773842     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1998.155     Document Type: Article

References (45)

1. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996; 28:1328-428.
2. Nomenclature and Criteria for Diagnosis of Ischemic Heart Disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Circulation 1979; 59:607-8.
3. Lee TH, Goldman L. Serum enzyme assays in the diagnosis of acute myocardial infarction. Recommendations based on a quantitative analysis. Ann Intern Med 1986; 105:221-33.
4. Lott JA, Stang JM. Differential diagnosis of patients with abnormal serum creatine kinase isoenzymes. Clin Lab Med 1989; 9:627-42.
5. Mair J, Morandell D, Genser N, Lechleitner P, Dienstl F, Puschendorf B. Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponin I and T for acute myocardial infarction. Clin Chem 1995; 41:1266-72.
6. Bhayana V, Henderson AR. Biochemical markers of myocardial damage. Clin Biochem 1995; 28:1-29.
7. Vaidya HC. Myoglobin: an early biochemical marker for the diagnosis of acute myocardial infarction. J Clin Immunoassay 1994; 17:35-9.
8. Brogan GX, Friedman S, McCuskey C, Cooling DS, Berrutti L, Thode HC, et al. Evaluation of a new rapid quantitative immunoassay for serum myoglobin versus CK-MB for ruling out acute myocardial infarction in the emergency department. Ann Emerg Med 1994; 24:665-71.
9. Montague C, Kircher T. Myoglobin in the early evaluation of acute chest pain. Am J Clin Pathol 1995; 104:472-6.
10. Apple FS. Glycogen phosphorylase BB and other cardiac proteins: challenges to creatine kinase MB as the marker for detecting myocardial injury. Clin Chem 1995; 41:963-5.
11. Panteghini M. Diagnostic application of CK-MB mass determination. Clin Chim Acta 1998; 272:23-31.
12. Panteghini M. Enzyme and muscle disease. Curr Opin Rheumatol 1995; 7:469-74.
13. Tymchak WJ, Armstrong PW. Spectrum of ischemic heart disease and the role of biochemical markers. Clin Lab Med 1997; 17:701-25.
14. Rottbauer W, Greten T, Muller-Bardoff M, Remppis A, Zehelein J, Grunig E, et al. Troponin T: a diagnostic marker for myocardial infarction and minor cardiac cell damage. Eur Heart J 1996; 17 Suppl F:3-8.
15. Hamm CW. Cardiac-specific troponins in acute coronary syndromes. In: Braunwald E, editor. Heart disease: a textbook of cardiovascular medicine. 5th ed. Philadelphia: Saunders, 1997; Update 3:1-10.
16. Luscher MS, Thygesen K, Ravkilde J, Heickendorff L; for the TRIM study group. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. Circulation 1997; 96:2578-85.
17. Altinier S, Amboni P, Bonora R, Brustia A, Dolci A, Lachin M, et al. Multicenter evaluation of five methods for myoglobin determination. Biochim Clin 1997; 21:429.
18. Green S, Onoroski M, Moore R, Wu A, Leher M, Vaidya H. Use of proposed CK-MB standardization material for calibration of mass measurements: clinical correlation of patient sera. Clin Chem 1993; 39:1269.
19. Henderson AR, Krishnan S, Webb S, Cheung CM, Nazir DJ, Richardson H. Proficiency testing of creatine kinase and creatine kinase-2: the experience of the Ontario Laboratory Proficiency Testing Program. Clin Chem 1998; 44:124-33.
20. Panteghini M, Bonora R, Pagani F. Automated immunoassay of cardiac troponin I in serum evaluated. Clin Chem 1997; 43:195-6.
21. Panteghini M, Bonora R, Pagani F, Buffoli F, Cuccia C. Rapid, highly sensitive immunoassay for determination of cardiac troponin I in patients with myocardial cell damage. Clin Chem 1997; 43:1464-5.
22. Katrukha AG, Bereznikova AV, Esakova TV, Pettersson K, Lovgren T, Severina ME, et al. Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. Clin Chem 1997; 43:1379-85.
23. McPherson PH, Buechler KF. Characterization and measurement of troponin I, troponin T and troponin complexes in blood from AMI patients. Clin Chem 1997; 43:S136.
24. Katrukha A, Severina M, Bereznikova A, Esakova T, Gusev N, Pettersson K, et al. Phosphorylation of human cardiac troponin I by protein kinase A affects its immunological activity. Presented at International Congress on Clinical Enzymology; 1996 July 13-16; Cambridge, UK.
25. Muller-Bardorff M, Hallermayer K, Schroder A, Ebert C, Borgya A, Gerhardt W, et al. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. Clin Chem 1997; 43:458-66.
26. Collinson PO. To T or not to T, that is the question. Clin Chem 1997; 43:421-3.
27. Henderson AR. An overview and ranking of biochemical markers of cardiac disease. Strengths and limitations. Clin Lab Med 1997; 17:625-54.
28. Waskiewicz D, Lavigne L, Salhaney J, Annunziato M, Fagan G, Whiteley G. Rapid self-contained troponin I assay for the Behring Opus immunoassay system. Clin Chem 1995; 41:S63.
29. Flaa C, Sabucedo A, Geist W, DeMarco C, Troy S, Chavaillaz P, et al. Development of a rapid, automated procedure forthe determination of troponin-I on the Stratus immunochemistry analyzer. Clin Chem 1993;39:1273.
30. Panteghini M, Pagani F. Biological variation of myoglobin in serum. Clin Chem 1997; 43:2435.
31. Ross SM, Fraser CG. Biological variation of cardiac markers: analytical and clinical considerations. Ann Clin Biochem 1998; 35:80-4.
32. Kuhr LP, Baum H, Schweigert R, Hafner G, Prellwitz W, Neumeier D. Evaluation of a rapid, quantitative cardiac troponin I immunoassay. Eur J Clin Chem Clin Biochem 1997; 35:399-404.
33. Waskiewicz D, Salhaney J, Lavigne L, Fagan G, Whiteley G. Sample stability differences among troponin I kits. Clin Chem 1996; 42:S311.
34. Henderson AR, Gerhardt W, Apple FS. Summary, with extrapolations, of a roundtable on the use of biochemical markers in the diagnosis and theory of monitoring of patients with ischemic heart disease. Clin Chim Acta 1998; 272:93-100.
35. Anderson FP, Jesse RL, Nicholson CS, Miller WG. The costs and effectiveness of a rapid diagnostic and treatment protocol for myocardial infarction. In: Bowie LJ, editor. Assessing clinical outcomes. Utilizing appropriate laboratory testing to decrease the Healthcare costs and improve patient outcomes. Washington DC: AACC Leadership Series, 1996:20-4.
36. Gerhardt W, Ljungdahl L, Collinson PO, Lovis C, Mach F, Sylven C, et al. An improved rapid troponin T test with a decreased detection limit: a multicentre study of the analytical and clinical performance in suspected myocardial damage. Scand J Clin Lab Invest 1997; 57:549-58.
37. Panteghini M, Bonora R. A rapid bedside immunochromatographic assay for cardiac troponin I evaluated. Clin Chem 1997; 43:S157-8.
38. Panteghini M, Pagani F. Characterization of a rapid immunochromatographic assay for simultaneous detection of high concentrations of myoglobin and CK-MB in whole blood. Clin Chem 1996; 42:1292-3.
39. Roth A, Malov N, Bloch Y, Golovner M, Slesarenko Y, Naveh R, et al. Assessment of a CK-MB/myoglobin kit in the pre-hospital setting in patients presenting with acute non traumatic chest pain. The 'Shahal' experience. Eur Heart J 1998; submitted.
40. Wu AHB. Use of cardiac markers as assessed by outcome analysis. Clin Biochem 1997; 30:339-50.
41. Sandberg S. Systematic reviews of diagnostic tests-a new challenge for laboratory medicine. Scand J Clin Lab Invest 1997; 57:369-72.
42. Maseri A, Rebuzzi AG, Cianflone D. Need for a composite risk stratification of patients with unstable coronary syndromes tailored to clinical practice. Circulation 1997; 96:4141-2.
43. Lindahl B, Venge P, Wallentin L; for the Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. J Am Coll Cardiol 1997; 29:43-8.
44. Committee "Standardization of Immunoassays", German Society for Laboratory Medicine. Recommendations on laboratory testing in acute ischemic heart diseases. J Lab Med 1997; 21:402-8.
45. Green S, Onoroski M, Moore R, Wu A, Leher M, Vaidya H, and the AACC CK-MB mass assay standardization subcommittee (MB-MASS). Standardization of CK-MB mass immunoassays. Clin Chem 1994; 40:1032.